About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials in Georgia | 690 Studies

Clinical Trials Breast CancerGeorgia

Breast Cancer Clinical Trials in Georgia

Find 690 clinical trials for breast cancer near Georgia. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Georgia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 361-380 of 690 trials

Active not recruitingTesting the Addition of Copanlisib to Eribulin in Metastatic Triple Negative Breast CancerThis phase I/II trial studies the side effects and best dose of copanlisib and how well it works when given together with eribulin in treating patients with triple negative breast…NCT04345913·Sacramento, California and 42 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

Active not recruitingHormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)This randomized phase III trial studies the best individual therapy for women who have node-negative, estrogen-receptor positive breast cancer by using a special test (Oncotype…NCT00310180·Anniston, Alabama and 1221 others

CompletedRadiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate CancerRATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. It is not yet known which radiation therapy regimen is more effective for bone metastases.NCT00003162·Birmingham, Alabama and 252 others

Active not recruitingA Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer)This is a Phase III, global, randomized, open-label, multicenter, study evaluating the efficacy and safety of adjuvant giredestrant compared with physician's choice of endocrine…NCT04961996·Daphne, Alabama and 620 others

CompletedStudy of Cabozantinib (XL184) in Adults With Advanced MalignanciesThis is a Phase 2 study to evaluate the efficacy and safety of cabozantinib (XL184) in subjects with selected advanced tumor types.NCT00940225·Scottsdale, Arizona and 46 others

CompletedTAC Versus TC for Adjuvant Breast CancerThe purpose of this research study is to find out what effects (good and bad) TC or TAC has on early stage HER2- breast cancer.NCT00493870·Birmingham, Alabama and 94 others

CompletedCancer Symptom Data From Multiple Treatment CentersBackground: \- Cancer and cancer treatments can cause symptoms and side effects. Pain, fatigue, and emotional distress are three common symptoms.NCT01547845·Orange, California and 14 others

CompletedSafety and Efficacy of LibiGel® for Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal WomenThis study is a randomized, double-blind, placebo-controlled, adaptive design, multi-center study of the long-term cardiovascular and breast safety of LibiGel in the treatment of…NCT00612742·Birmingham, Alabama and 148 others

CompletedPhase I-II Study to Determine the Maximum Tolerated Dose (MTD) of AUY922 in Advanced Solid Malignancies, and Efficacy in HER2+ or ER+ Locally Advanced or Metastatic Breast Cancer PatientsThis is a phase I/II, open-label, multicenter study of AUY922 administered intravenously in patients with advanced solid malignancies to determine the maximum tolerated dose.NCT00526045·Los Angeles, California and 9 others

CompletedCommunity Oncology Setting Cost Analysis and Disease Outcomes of Taxane Use in Metastatic Breast CancerThis is a retrospective medical record abstraction study.NCT00876070·Atlanta, Georgia and 1 other

SuspendedCANscriptTM Clinical Outcomes in a Real-World Setting (ANCERS)-2The purpose of this study is to test the CANscript™ sensitivity assay, which is a new and different assay developed to test the sensitivity of different cancer types to physician…NCT03253575·Gilbert, Arizona and 29 others

CompletedThe BEACON Study (Breast Cancer Outcomes With NKTR-102)The study is designed as an open-label, randomized, parallel, two arm, multicenter, international Phase 3 study in patients with recurrent or metastatic breast cancer previously…NCT01492101·Flagstaff, Arizona and 152 others

CompletedBreast Ultrasound and Mammography in Screening Women at High Risk for Breast CancerRATIONALE: Screening tests such as ultrasound and mammography may help doctors detect cancer cells early and plan more effective treatment for breast cancer.NCT00072501·Los Angeles, California and 19 others

CompletedStudy of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Participants With HR+/HER2- Metastatic Breast CancerThe primary objective of this study is to assess and compare the efficacy and safety of sacituzumab govitecan-hzi versus treatment of physician's choice (TPC) in participants with…NCT03901339·Avondale, Arizona and 112 others

Active not recruitingComparing Single vs Multiple Dose Radiation for Cancer Patients With Brain Metastasis and Receiving ImmunotherapyThis study is designed to see if we can lower the chance of side effects from radiation in patients with breast, kidney, small cell lung cancer, non-small cell lung cancer or…NCT05703269·Savannah, Georgia and 33 others

CompletedAdjuvant Epirubicin/Cytoxan Followed By A Taxane VS. Epirubicin/Taxane As Treatment For Node-Positive Breast CancerThe purpose of this study is to compare two combinations of drugs, epirubicin given with a taxane (ET) or epirubicin given with cyclophosphamide (cytoxan) and followed by a taxane…NCT00140075·Mobile, Alabama and 53 others

TerminatedA Study of Lerociclib in Participants With Advanced Breast CancerThis is a multicenter, single-arm, open-label study to evaluate the safety and efficacy of lerociclib in combination with standard endocrine therapy in female or male participants…NCT05085002·Jacksonville, Florida and 20 others

CompletedDelphinus SoftVue Prospective Case Collection - ARM 1The SoftVue™ is a whole breast ultrasound system with an automated scanning curvilinear ring-array transducer that employs UST.NCT03257839·Los Angeles, California and 9 others

Active not recruitingPALbociclib CoLlaborative Adjuvant StudyThis is a prospective, two arm, international, multicenter, randomized, open-label Phase III study evaluating the addition of 2 years of palbociclib to standard adjuvant endocrine…NCT02513394·Mobile, Alabama and 436 others

CompletedA Study of Tucatinib vs. Placebo in Combination With Capecitabine & Trastuzumab in Patients With Advanced HER2+ Breast CancerThis study is being done to see if tucatinib works better than placebo to help patients who have a specific type of breast cancer called HER2 positive breast carcinoma.NCT02614794·Birmingham, Alabama and 175 others

PreviousPage 19 of 35Next

Other Conditions in Georgia

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma